MedPath

AUSTRALIAN NATURAL HEALTH PHARMACEUTICALS PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

17

TGA:17

Drug Approvals

Biosis Bilberry 10,000 Plus Lutein and Zeaxanthin (429631)

Product Name
Biosis Bilberry 10,000 Plus Lutein and Zeaxanthin
Approval Date
Dec 4, 2023
TGA

Biosis Ginkgo 6000 mg plus Brahmi 3000 mg (422311)

Product Name
Biosis Ginkgo 6000 mg plus Brahmi 3000 mg
Approval Date
Sep 25, 2023
TGA

Biosis Liquid Calcium Plus Vitamin D3 (422312)

Product Name
Biosis Liquid Calcium Plus Vitamin D3
Approval Date
Sep 25, 2023
TGA

Biosis Evening Primrose Oil 1000 mg (420811)

Product Name
Biosis Evening Primrose Oil 1000 mg
Approval Date
Sep 1, 2023
TGA

Biosis Glucosamine 1500 mg Complex Plus Chondroitin, Selenium and MSM (420192)

Product Name
Biosis Glucosamine 1500 mg Complex Plus Chondroitin, Selenium and MSM
Approval Date
Aug 29, 2023
TGA

Biosis Propolis 2000 mg (419093)

Product Name
Biosis Propolis 2000 mg
Approval Date
Aug 21, 2023
TGA

Biosis High Strength Milk Thistle 32000 mg (Super Liver Tonic) (419133)

Product Name
Biosis High Strength Milk Thistle 32000 mg (Super Liver Tonic)
Approval Date
Aug 21, 2023
TGA

Biosis Co Enzyme Q10 150 mg (419132)

Product Name
Biosis Co Enzyme Q10 150 mg
Approval Date
Aug 21, 2023
TGA

Biosis Squalene 1000 mg (419134)

Product Name
Biosis Squalene 1000 mg
Approval Date
Aug 21, 2023
TGA

Biosis Bilberry 10,000 mg Plus Lutein and Zeaxanthin (419135)

Product Name
Biosis Bilberry 10,000 mg Plus Lutein and Zeaxanthin
Approval Date
Aug 21, 2023
TGA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.